Envestnet Asset Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,946
Closed -$260K 4103
2022
Q2
$260K Sell
7,946
-46,775
-85% -$1.48M ﹤0.01% 3441
2022
Q1
$1.44M Buy
54,721
+13,386
+32% +$327K ﹤0.01% 2398
2021
Q4
$981K Buy
41,335
+5,902
+17% +$146K ﹤0.01% 2641
2021
Q3
$889K Buy
35,433
+4,385
+14% +$112K ﹤0.01% 2625
2021
Q2
$807K Buy
+31,048
New +$845K ﹤0.01% 2675
2018
Q3
Sell
-1,181
Closed -$41K 2841
2018
Q2
$41K Sell
1,181
-11
-0.9% -$386 ﹤0.01% 2261
2018
Q1
$40K Sell
1,192
-3,146
-73% -$99.6K ﹤0.01% 2211
2017
Q4
$166K Buy
4,338
+266
+7% +$10.6K ﹤0.01% 1921
2017
Q3
$154K Sell
4,072
-219
-5% -$7.73K ﹤0.01% 1930
2017
Q2
$161K Sell
4,291
-8,510
-66% -$307K ﹤0.01% 1946
2017
Q1
$504K Buy
12,801
+2,778
+28% +$104K ﹤0.01% 1516
2016
Q4
$348K Buy
10,023
+2,295
+30% +$90.1K ﹤0.01% 1660
2016
Q3
$304K Sell
7,728
-2,140
-22% -$85.4K ﹤0.01% 1832
2016
Q2
$373K Sell
9,868
-94
-0.9% -$3.15K ﹤0.01% 1784
2016
Q1
$383K Buy
9,962
+632
+7% +$23.5K ﹤0.01% 1763
2015
Q4
$448K Buy
9,330
+1,054
+13% +$48.8K ﹤0.01% 1655
2015
Q3
$326K Buy
8,276
+2,593
+46% +$110K ﹤0.01% 1794
2015
Q2
$242K Sell
5,683
-4,118
-42% -$164K ﹤0.01% 2044
2015
Q1
$387K Buy
9,801
+3,897
+66% +$144K ﹤0.01% 1667
2014
Q4
$213K Sell
5,904
-2,889
-33% -$97K ﹤0.01% 993
2014
Q3
$259K Buy
8,793
+8,626
+5,165% +$238K ﹤0.01% 999
2014
Q2
$4K Sell
167
-146
-47% -$3.61K ﹤0.01% 2383
2014
Q1
$8K Sell
313
-31
-9% -$781 ﹤0.01% 1980
2013
Q4
$8K Sell
344
-57
-14% -$1.1K ﹤0.01% 1853
2013
Q3
$6K Buy
+401
New +$5.36K ﹤0.01% 1884

Other funds holding NTUS

Envestnet Asset Management's NTUS Position: Q3 2022 in Review

Envestnet Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 7,946 shares — an estimated $260K sold.

Envestnet Asset Management first reported a position in NTUS in Q3 2013 and held it in 25 quarters. The position peaked at $1.44M in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Envestnet Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 7,946 Natus Medical Inc shares in Q3 2022, an estimated $260K.
  • Envestnet Asset Management first reported a position in Natus Medical Inc in Q3 2013 and held it in 25 quarters.
  • Envestnet Asset Management's Natus Medical Inc position peaked at $1.44M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.